Strong credit performance and low losses
No new non-accruals in the quarter; non-accrual rate declined to 1% at fair value. Historical loss experience remains low with average annual loss rates of ~31 basis points since inception.
We use cookies to improve your experience, analyze site usage, and show relevant ads. Go to our Privacy Policy for details.
The call described a quarter with near-term earnings pressure driven by lower base rates, spread widening and slower deal activity that led to a NAV decline and a base dividend reset. However, underlying credit fundamentals remained solid (no new non-accruals, healthy borrower EBITDA/revenue growth), the balance sheet and liquidity were materially strengthened (net leverage reduced to 1.13x, >$4B liquidity, Moody's upgrade), active share repurchases and a larger repurchase authorization were executed, and management emphasized readiness to deploy into a more attractive spread environment. On balance, the strengths in credit performance, capital position, and long-term track record outweighed the transitory valuation and earnings headwinds.
Management guided that OBDC is resetting its base dividend to $0.31 per share for Q2 (implying ~8.6% yield on NAV and >10% yield at current share price) while keeping the supplemental framework to pay 50% of NII above the base; Q1 adjusted NII was $0.31/share with spillover income of ~$0.28/share and NAV of $14.41 (down from $14.81, ~75% of the decline driven by spread widening). They said the portfolio remains healthy—non‑accruals at ~1% (three‑year avg ~1%), interest coverage ~2.0x, average loan marked at 95.4, average spread in the book 560 bps, average LTV 47% (software ~48%)—and emphasized lower leverage (ending net leverage 1.13x, in a 0.90x–1.25x target range), ample liquidity (>$4B after a $400M note), recent fundings of $525M vs ~ $1.5B of repayments/sales, $35M of buybacks this quarter ($183M over two quarters) under a new $300M repurchase authorization (~$265M remaining), and an expectation that spreads (currently ~50–75 bps wider on new deals) and deal activity should create opportunities to selectively deploy capital.
No new non-accruals in the quarter; non-accrual rate declined to 1% at fair value. Historical loss experience remains low with average annual loss rates of ~31 basis points since inception.
Adjusted net investment income (NII) was $0.31 per share in Q1 2026; the Board set the Q2 base dividend at $0.31 per share and maintained the supplemental dividend framework (50% of NII above the base).
Liquidity expanded to over $4 billion (cash + facility capacity) following a $400 million unsecured note offering post-quarter; net leverage reduced to 1.13x (lowest level in two years) and is within the target range of 0.90x–1.25x.
Moody's upgraded the company to Baa2 in January, and the subsequent $400M unsecured note offering saw strong institutional demand, signaling market confidence in OBDC's credit profile.
Repurchased $35 million of stock in Q1 (total $183M over the past two quarters). Board authorized a new $300 million repurchase program in February; approximately $265M remains available after Q1 activity.
Broadly diversified across ~30 industries with average position size of ~40 bps; borrower revenue and EBITDA grew year-over-year in the high single digits, software borrowers showed low double-digit EBITDA growth.
Received meaningful repayments including Intelerad (full repayment after $2.3B sale to GE Healthcare) which reduced software exposure from ~19% to ~16% of the portfolio.
Increased allocation to life sciences specialty finance vehicle (LSI) supporting a $1B financing; LSI has generated returns of >14% to OBDC since inception, highlighting attractive JV/specialty finance economics.
Interest coverage improved to ~2.0x (up from trough ~1.6x); average loan marked at ~95.4 and current spread in book ~560 bps, underscoring expected recovery towards par on performing loans.
On its ten-year anniversary, the fund delivered a 9.6% annualized total return since inception, reinforcing a demonstrated long-term performance history through multiple cycles.
Good morning, everyone, and welcome to the Blue Owl Capital Corporation's First Quarter 2026 Earnings Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to Mike Mosticchio, Head of BDC Investor Relations. Mike, please go ahead.
Thank you, Operator, and welcome to Blue Owl Capital Corporation's first quarter 2026 earnings conference call. Joining me today are Craig Packer, Chief Executive Officer, Logan Nicholson, President, and Jonathan Lamm, Chief Financial Officer. I would like to remind listeners that remarks made during today's call may contain forward-looking statements which are not guarantees of future performance or results and involve a number of risks and uncertainties that are outside of the company's control. Actual results may differ materially from those in forward-looking statements as a result of a number of factors, including those described in OBDC's filings with the SEC. The company assumes no obligation to update any forward-looking statements. We would also like to remind everyone that we will refer to non-GAAP measures on the call which are reconciled to GAAP figures in our earnings presentation available on the Events and Presentations section of our website. Certain information discussed on this call and in the company's earnings materials, including information related to portfolio companies, was derived from third-party sources and has not been independently verified. The company makes no such representations or warranties with respect to this information.
Yesterday, OBDC issued its financial results ...
May 6th, 2026
February 18th, 2026
November 5th, 2025
August 6th, 2025
May 7th, 2025
February 19th, 2025
November 6th, 2024
August 7th, 2024
May 8th, 2024
February 21st, 2024
November 8th, 2023
August 9th, 2023
May 10th, 2023